Ventyx Biosciences
(NASDAQ) VTYX
Ventyx Biosciences Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$106.61M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VTYX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Ventyx Biosciences
Industry
Pharmaceuticals
Sector
Health CareEmployees
82
CEO
Raju S. Mohan, PhD
Website
www.ventyxbio.comHeadquarters
San Diego, CA 92024, US
VTYX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-48%
Return on Capital
-58%
Return on Assets
-50%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$148.45M
EBITDA
$147.10M
Operating Cash Flow
$130.87M
Capital Expenditure
$241.00K
Free Cash Flow
$131.11M
Cash & ST Invst.
$217.32M
Total Debt
$10.79M
Ventyx Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
81
N/A
Net Income
$22.83M
+35.2%
EBITDA
$22.77M
+40.5%
Quarterly Fundamentals
Net Cash
$182.61M
-30.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$8.84M
-11.8%
Short Term Debt
$1.18M
+16.9%
Return on Assets
-50.41%
N/A
Return on Invested Capital
-58.30%
N/A
Free Cash Flow
$17.56M
+50.5%
Operating Cash Flow
$17.51M
+50.6%